
The NHS is facing a “critical threat” from drug price hikes as pharmaceutical companies bow to pressure from Donald Trump, experts have warned.
The US president has announced a fresh round of tariffs on pharmaceutical firms, with 100 per cent tariffs on branded medicines from October 1.